IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. - Burns, L J; Weisdorf, D J; DeFor, T E; Vesole, D H; Repka, T L; Blazar, B R; Burger, S R; Panoskaltsis-Mortari, A; Keever-Taylor, C A; Zhang, M-J; Miller, J S (Bone Marrow Transplantation, 2003)